China's genomics giant to make stock-market debut
Once the world's biggest DNA sequencer for research, BGI is now looking to medical applications to boost profits.
David had worked in Japan for several years before moving into journalism with Nature in 2000. His varied employment history includes translation for a semiconductor-manufacturing equipment company and teaching history to foreign exchange students. In addition to covering the Asian-Pacific region, David's interests encompass materials, Earth science and intellectual property.